SINGH BROTHERS FINED RS 2,600 CR FOR HIDING FACTS FROM DAIICHI

New Delhi, Medicare News, May 15, 2016

Billionaire businessman Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh have been fined nearly Rs 2,600 crore, media reports say.
The erstwhile promoters of drug maker Ranbaxy were penalised for concealing and misrepresenting facts from Japanese pharmaceutical company, Daiichi Sankyo about its 2008 deal involving the sale of controlling stake in Ranbaxy.

The fine was decided by Singapore International Arbitration Centre (SIAC), which heard an arbitration case filed by Daiichi Sankyo in 2013. The Singh brothers, former Ranbaxy owners, had sold their stake to Daiichi Sankyo for $2.4 billion in 2008.

Japanese drugmaker Daiichi Sankyo later sold Ranbaxy to Mumbai-based Sun Pharma. The Singh brothers now run hospitals under the Fortis brand. They also own financial services firm Religare Enterprises.

Related Posts

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

GSK Pharma forays into gynaecological cancer treatment in India

GSK Pharma forays into gynaecological cancer treatment in India

Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

DCGI issued alert regarding theft of Novo Nordisk injectables

DCGI issued alert regarding theft of Novo Nordisk injectables

Two firms fined for selling spurious cosmetic products

Two firms fined for selling spurious cosmetic products